The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer’s disease. Kisunla is an IV infusion therapy given once a month to people in the early stages of Alzheimer’s, according to the Alzheimer’s Association. The treatment destroys amyloid plaques in the brain to slow the progression of the disease.
This article was originally published on MedicalXpress.com
Fostering a rewarding and fulfilling relationship is no easy task. You and your partner are only human, and, as the saying goes, you are going to make mistakes. However, learning the common relationship mistakes and […]
Do you want to know more about attachment types and adult relationships? If so, you’ve come to the right place! In this blog, we’ll examine how different attachment styles impact our relationships and how understanding […]
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
© 2024 SimplyWell.ca